Common arthritis drugs reduce systemic Sjögren's disease activity in 24 weeks
byUniversity Medical Center UtrechtESSDAI scores over 24 weeks of treatment with leflunomide–hydroxychloroquine or placebo: (A) Mean ESSDAI corrected for baseline, indicating the treatment effect of l
Updated on: June 21,2026
Common arthritis drugs reduce systemic Sjögren's disease activity in 24 weeks
byUniversity Medical Center UtrechtESSDAI scores over 24 weeks of treatment with leflunomide–hydroxychloroquine or placebo: (A) Mean ESSDAI corrected for baseline, indicating the treatment effect of l
Updated on:June 21,2026
